Log in
Topical analgesic and bladder protectant

Dimethyl sulfoxide

Dimethyl sulfoxide (DMSO) is an organic solvent with analgesic, anti-inflammatory, and membrane-penetrating properties. It is FDA-approved for intravesical treatment of interstitial cystitis and used topically for musculoskeletal pain, though the latter is not FDA-approved. The most characteristic feature is its ability to rapidly penetrate biological membranes and produce a distinctive garlic-like taste and odor.

Practice questionsHigh-yield facts
Drug classTopical analgesic and bladder protectant
MechanismMembrane penetration, free radical scavenging, anti-inflammatory
Main usesInterstitial cystitis (intravesical), topical musculoskeletal pain
Key adverse effectGarlic-like breath and body odor
6 min readFor medical studentsUpdated 2026-10-15

Mechanism of action

Dimethyl sulfoxide is a highly polar aprotic solvent with multiple proposed mechanisms of action, though the exact therapeutic mechanisms remain incompletely understood.

Primary mechanisms include:

  • Membrane penetration: DMSO readily crosses biological membranes due to its amphipathic nature, potentially carrying other molecules with it and altering membrane permeability
  • Free radical scavenging: Acts as a hydroxyl radical scavenger, reducing oxidative stress and inflammation
  • Anti-inflammatory effects: Inhibits prostaglandin synthesis and reduces inflammatory mediator release
  • Mast cell stabilization: May reduce histamine release, particularly relevant in interstitial cystitis
  • Collagenase inhibition: Reduces collagen breakdown in inflamed tissues
  • Local anesthetic properties: May stabilize nerve conduction and reduce pain signaling
  • Vasodilation: Increases local blood flow to treated areas

When used intravesically for interstitial cystitis, DMSO may desensitize bladder pain receptors, reduce inflammation of the bladder wall, and dissolve abnormal protein deposits. The garlic-like odor characteristic of DMSO therapy results from its metabolism to dimethyl sulfide, which is eliminated via the lungs and skin.

High-yield for exams
  • DMSO produces characteristic garlic-like breath and body odor from dimethyl sulfide metabolite—most recognizable adverse effect
  • FDA-approved for intravesical treatment of interstitial cystitis; topical musculoskeletal use is NOT FDA-approved
  • Mechanism includes membrane penetration, free radical scavenging, and anti-inflammatory effects—no single receptor target
  • Can carry other molecules through biological membranes—apply only to clean skin to avoid systemic absorption of contaminants
  • Pregnancy category C with potential teratogenic effects in animals; use only if benefit outweighs risk
  • Long-term use may cause lens changes (animal data); consider baseline ophthalmologic exam for chronic therapy
  • Rapidly absorbed through skin and mucous membranes with systemic distribution within minutes
  • Hemolysis and hemoglobinuria are recognized adverse effects of intravesical DMSO administration

Indications

FDA-approved indication:

  • Interstitial cystitis (symptomatic relief): Intravesical instillation for chronic bladder pain, urgency, and frequency

Non-FDA-approved uses (topical):

  • Musculoskeletal pain and inflammation
  • Soft tissue injuries, sprains, and strains
  • Osteoarthritis and rheumatoid arthritis (symptom relief)
  • Reflex sympathetic dystrophy (complex regional pain syndrome)
  • Scleroderma (skin manifestations)
  • Keloid and hypertrophic scar reduction

Investigational uses:

  • Extravasation management (chemotherapy-induced tissue injury)
  • Acute stroke (neuroprotection)
  • Amyloidosis
  • Herpes zoster (shingles)

The intravesical use for interstitial cystitis remains the primary evidence-based indication. Topical applications for musculoskeletal conditions are widely used but lack robust FDA approval and have mixed evidence for efficacy.

Pharmacokinetics

Absorption: DMSO is rapidly absorbed through skin, mucous membranes, and bladder mucosa. Topical application achieves systemic absorption within minutes. Intravesical instillation results in bladder wall penetration and systemic absorption.

Distribution: Widely distributed throughout body tissues due to excellent membrane permeability. Crosses blood-brain barrier. Penetrates into synovial fluid, cartilage, and other connective tissues.

Metabolism: Metabolized primarily by oxidation to dimethyl sulfoxide-2 (DMSO2) and reduction to dimethyl sulfide (DMS). The conversion to dimethyl sulfide accounts for the characteristic garlic-like odor on breath and skin that appears within minutes of administration and may persist for 24-72 hours.

Elimination: Excreted in urine as unchanged DMSO and DMSO2. Dimethyl sulfide is eliminated via lungs (breath) and through skin. Elimination half-life is approximately 11-14 hours for DMSO and its metabolites.

Special considerations: The garlic odor may be socially problematic and serves as a marker of systemic absorption. Patients should be counseled about this persistent odor before treatment.

Adverse effects

Very common (>10%):

  • Garlic-like odor on breath and skin (nearly universal with intravesical use)
  • Garlic-like taste immediately after intravesical instillation
  • Local discomfort or burning at application site
  • Bladder spasm and discomfort (intravesical)

Common (1-10%):

  • Nausea
  • Headache
  • Dizziness
  • Drowsiness
  • Contact dermatitis or erythema (topical use)
  • Chemical cystitis (intravesical)
  • Hematuria (microscopic)

Less common but clinically significant:

  • Lens changes and visual disturbances: Long-term high-dose use has been associated with lens opacities in animal studies; routine ophthalmologic monitoring is recommended for prolonged therapy
  • Hemolysis and hemoglobinuria: Recognized complication of intravesical DMSO administration, presenting with anemia and red-tinged urine
  • Hypersensitivity reactions (rare)
  • Bronchospasm (in susceptible individuals)
  • Anaphylactoid reactions (rare)

Dermatologic effects:

  • Pruritus
  • Erythema and scaling
  • Vesiculation with concentrated solutions
  • Hyperpigmentation or hypopigmentation

Gastrointestinal:

  • Abdominal cramps
  • Diarrhea

The characteristic garlic odor, while not medically serious, is often the limiting factor for patient acceptance and compliance. Patients should be thoroughly counseled about this inevitable effect.

Contraindications and warnings

Absolute contraindications:

  • Hypersensitivity to DMSO or any component
  • Urinary tract malignancy (for intravesical use)

Warnings and precautions:

  • Ocular effects: Prolonged or high-dose use may cause lens changes. Baseline and periodic ophthalmologic examinations are recommended for chronic therapy, though routine monitoring is not standard for short-term intravesical treatment
  • Skin integrity: Should not be applied to broken or abraded skin due to enhanced systemic absorption and potential for carrying contaminants into tissues
  • Chemical purity: Only pharmaceutical-grade DMSO should be used medically; industrial-grade DMSO may contain toxic impurities
  • Hepatic and renal function: Use with caution in patients with significant hepatic or renal impairment
  • Cardiac disease: May cause histamine release; use cautiously in patients with cardiovascular disease

Pregnancy and lactation:

  • Pregnancy category C: Animal studies show potential teratogenic effects at high doses. Use only if benefit outweighs risk
  • Lactation: Unknown if excreted in breast milk; caution advised

Pediatric use: Safety and efficacy not established in children for most indications.

Special populations: Elderly patients may be more sensitive to systemic effects and should be monitored closely.

Important safety note: Patients should ensure the skin is clean before topical application, as DMSO can carry other substances (including toxins or contaminants) through the skin and into systemic circulation.

Drug interactions

DMSO has relatively few direct pharmacokinetic drug interactions, but its unique membrane-penetrating properties create important clinical considerations.

Enhanced drug absorption:

  • DMSO can increase the absorption and potency of other topically applied medications due to its carrier properties
  • May enhance systemic absorption of concomitant topical agents, potentially increasing both therapeutic and toxic effects
  • Particular caution with topical corticosteroids, NSAIDs, or other active agents

Specific interactions:

  • Sulindac: May increase sulindac peripheral neuropathy risk (case reports)
  • Anticholinergic agents: Additive anticholinergic effects theoretically possible with intravesical use
  • Other bladder irritants: Concomitant use of other intravesical agents should be carefully timed

General considerations:

  • Avoid applying DMSO over areas where other topical medications have been recently applied
  • Clean skin thoroughly before application to prevent inadvertent systemic absorption of surface contaminants
  • Use caution with medications that have narrow therapeutic windows if systemic absorption could be enhanced
  • Limited data exist on most drug-drug interactions due to unique pharmacology

Alcohol: Some sources suggest avoiding alcohol during DMSO therapy due to potential for additive effects, though clinical significance is unclear.

The primary concern with DMSO is not traditional drug interactions but rather its ability to serve as a vehicle that enhances the penetration of other substances through biological membranes.

Clinical pearls

High-yield exam and clinical concepts:

  • The garlic-like odor on breath and skin is pathognomonic for DMSO therapy and results from dimethyl sulfide metabolite; counsel patients before initiating therapy as this is often the limiting factor for compliance
  • DMSO is one of the few FDA-approved intravesical therapies for interstitial cystitis
  • Only pharmaceutical-grade DMSO should be used clinically; industrial DMSO may contain impurities
  • The drug's ability to enhance penetration of other molecules through membranes is both therapeutically useful and a safety concern—never apply over dirty skin or in combination with other topical agents without careful consideration
  • Lens changes are a theoretical long-term concern from animal studies; baseline eye exams may be considered for chronic therapy
  • Hemolysis with intravesical use is a recognized complication that can present with anemia and hemoglobinuria
  • Garlic taste occurs within minutes of intravesical instillation due to rapid systemic absorption
  • DMSO crosses the blood-brain barrier and achieves wide tissue distribution
  • The membrane-penetrating property makes contamination a serious safety issue—always use clean application technique

Practice questions

1. A 45-year-old woman with chronic pelvic pain is diagnosed with interstitial cystitis after cystoscopy reveals glomerulations. She begins intravesical dimethyl sulfoxide therapy. Thirty minutes after her first instillation, she complains of a strong garlic taste in her mouth. Which of the following best explains this finding?

Answer: B. The garlic taste and odor are characteristic and expected effects of DMSO therapy caused by rapid systemic absorption through the bladder mucosa and subsequent metabolism to dimethyl sulfide, which is eliminated via the lungs and appears in breath within minutes. This is not a sign of improper technique, contamination, or allergy, and patients should be counseled about this inevitable effect before starting therapy. The garlic odor on breath and skin is the most recognizable adverse effect of DMSO and may persist for 24-72 hours.

2. A 62-year-old man with chronic knee osteoarthritis has been using industrial-grade dimethyl sulfoxide purchased online for topical pain relief. He applies it daily to his knee after showering without fully drying the area. Which aspect of his DMSO use poses the greatest safety concern?

Answer: B. The use of industrial-grade DMSO is the most serious concern because it may contain toxic impurities that will be carried systemically through the skin due to DMSO's membrane-penetrating properties. Only pharmaceutical-grade DMSO should be used medically. While application to wet or contaminated skin is also concerning because DMSO can carry surface substances into the body, the potential for toxic impurities in industrial-grade products represents a greater hazard. Topical use for osteoarthritis is common though not FDA-approved.

3. A clinical trial evaluates long-term dimethyl sulfoxide therapy for scleroderma. Which monitoring parameter is most important to include in the study protocol based on animal toxicity data?

Answer: C. Animal studies have demonstrated that long-term, high-dose DMSO exposure can cause lens opacities and visual disturbances, making ophthalmologic monitoring important for chronic therapy. While not standard for short-term intravesical use, baseline and periodic eye examinations are recommended when DMSO is used long-term for conditions like scleroderma. DMSO is not particularly associated with hepatotoxicity, bone marrow suppression, QT prolongation, or direct nephrotoxicity at therapeutic doses, though caution is warranted in patients with pre-existing organ dysfunction.

Frequently asked questions

How does DMSO work?

DMSO works through multiple mechanisms including penetrating biological membranes, scavenging free radicals, reducing inflammation by inhibiting prostaglandin synthesis, and stabilizing mast cells. When used for interstitial cystitis, it may desensitize bladder pain receptors and reduce bladder wall inflammation. Its ability to carry other molecules through membranes contributes to both therapeutic and safety considerations.

What are the side effects of DMSO?

The most characteristic side effect is a garlic-like odor on the breath and skin that occurs in nearly all patients and may persist for 24-72 hours. Other common effects include local burning or discomfort, headache, nausea, and contact dermatitis with topical use. For intravesical use, bladder spasm, chemical cystitis, and hemolysis with hemoglobinuria can occur. Long-term use may potentially cause lens changes, though this is primarily based on animal studies.

Is DMSO FDA-approved?

DMSO is FDA-approved specifically for intravesical (into the bladder) treatment of interstitial cystitis. However, topical use for musculoskeletal pain, arthritis, and soft tissue injuries is NOT FDA-approved despite being widely used. Only pharmaceutical-grade DMSO should be used medically, as industrial-grade products may contain toxic impurities. The intravesical formulation for interstitial cystitis remains the only evidence-based FDA-approved indication.

Why does DMSO cause garlic breath?

DMSO is metabolized in the body to dimethyl sulfide (DMS), a volatile compound with a distinctive garlic-like odor. This metabolite is eliminated through the lungs (causing garlic breath) and through the skin (causing body odor). The odor appears within minutes of administration and can persist for 24-72 hours after treatment. This effect is nearly universal with systemic absorption and serves as a marker that the drug has been absorbed.

Can DMSO be used with other topical medications?

DMSO should be used cautiously with other topical medications because it can act as a carrier that enhances the absorption of other substances through the skin. This may increase both therapeutic effects and potential toxicity of concomitant topical agents. It is important to apply DMSO only to clean skin and avoid using it over areas where other medications have been recently applied. The same membrane-penetrating property means it can carry surface contaminants into the body, creating a safety concern.

Conditions it is used for

Interstitial cystitisMusculoskeletal painOsteoarthritisSoft tissue injuriesRheumatoid arthritisSclerodermaComplex regional pain syndromeExtravasation injury
Pentosan polysulfateHyaluronic acidLidocaineHeparinDiclofenacCapsaicinKetoprofenAmitriptyline

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: G04BX13WHO ATC/DDD index: M02AX03

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.